Association Provides Seed Grants For Clinical Chemists

Clinical chemists relate the chemical composition of tissue and body fluids to different illnesses--a critical step in the diagnosis and treatment of diseases. For them, as for investigators in most other fields today, transforming an idea into reality requires extensive funding. Sylvia Daunert, an assistant research professor at the University of Kentucky, is conducting research involving time-resolved fluorescence, creating more selective and sensitive assays for biomolecules and other biolo

Written byJames Weil
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Sylvia Daunert, an assistant research professor at the University of Kentucky, is conducting research involving time-resolved fluorescence, creating more selective and sensitive assays for biomolecules and other biological compounds by using complexes of certain elements, such as europium, with fluorescent compounds. These complexes will fluoresce longer than compounds in existing biological and clinical samples and will bind either with antibodies or with the biomolecule being studied. This causes the fluorescent properties of the compound to be delayed, hence the name "time-resolved fluorescence."

Daunert was one of two recipients of $5,000 grants awarded last year by the Van Slyke Society, the philanthropic branch of the 40-year-old American Association for Clinical Chemistry (AACC), based in Washington, D.C. Despite its name, AACC includes members from countries outside the United States; the association currently has more than 10,000 members worldwide.

Daunert says that without such funding, ideas such as hers would never come to ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies